Evidence map›Paper›PMID 37959879›Full record

ReviewPolymers2023

Recent Advances in Molecularly Imprinted Polymers and Their Disease-Related Applications.

Celia Cabaleiro-Lago, Sylwia Hasterok, Anette Gjörloff Wingren, Helena Tassidis

Abstract readReview
In one paragraph

Review in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Celia Cabaleiro-LagoDepartment of Bioanalysis, Faculty of Natural Sciences, Kristianstad University, 291 39 Kristianstad, Sweden.ORCID 0000-0002-3200-9945
Sylwia HasterokDepartment of Biomedical Sciences, Faculty of Health and Society, Malmö University, 205 06 Malmö, Sweden.ORCID 0009-0008-6154-0322
Anette Gjörloff WingrenDepartment of Bioanalysis, Faculty of Natural Sciences, Kristianstad University, 291 39 Kristianstad, Sweden.ORCID 0000-0002-2993-0354
Helena TassidisDepartment of Bioanalysis, Faculty of Natural Sciences, Kristianstad University, 291 39 Kristianstad, Sweden.ORCID 0000-0003-4190-5431

Funding

Biofilms Research Center for Biointerfaces No number providedEuropean Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie 721297Kristianstad University No number providedMalmö University No number providedthe Malmö Cancer Center, Malmö, Sweden No number provided
6 · The paper itself

Abstract

Molecularly imprinted polymers (MIPs) and the imprinting technique provide polymeric material with recognition elements similar to natural antibodies. The template of choice (i.e., the antigen) can be almost any type of smaller or larger molecule, protein, or even tissue. There are various formats of MIPs developed for different medical purposes, such as targeting, imaging, assay diagnostics, and biomarker detection. Biologically applied MIPs are widely used and currently developed for medical applications, and targeting the antigen with MIPs can also help in personalized medicine. The synthetic recognition sites of the MIPs can be tailor-made to function as analytics, diagnostics, and drug delivery systems. This review will cover the promising clinical applications of different MIP systems recently developed for disease diagnosis and treatment.

Indexed as

biomarkerdiagnosticsdiseasemedical applicationsmolecularly imprinted polymerssensor

Identifiers

PMID37959879
PMCPMC10649583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.